#ACTT

Eric Meyerowitz, MD

EricMeyerowitz

Thoughts on RECOVERY preprint: dexamethasone as treatment for COVID-19 @AaronRichterman https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1 Is the finding of no

Christopher J. Colombo, MD

colombocj1

1/ In support of well-conducted trials, & proper scientific conclusions: A thread. Special Thanks to Andre Kalil, MD at University of Nebraska Medical Center, for content creation & encouragement. I

Francisco Marty, MD

FranciscoMarty_

Tabulated the topline results released by the #recoverytrial team on #hydroxychloroquine & #dexamethasone, and went over their protocol (https://www.recoverytrial.net/results ) to better digest them.Basic stuff:- hospitalized patie

Infectious Diseases Fellows Network

ID_fellows

1/ A 56M with DM & CKD presents with severe dyspnea, cough & fever. His symptoms began 4 days ago and have progressively gotten worse. He requires 4L of O2.

Nida Qadir, MD

NidaQadirMD

Just published in @BMJ_latest, an update to our @WHO living guideline on drugs for #COVID19 – this update focuses on #remdesivir & was informed by the results of 4 trials

Francisco Marty, MD

FranciscoMarty_

It took a while to digest the details of over 600 pages, but here is my review and comparative analysis of the #ACTT2 trial that compared #baricitinib vs. #placebo among

Erin McCreary

ErinMcCreary

With the Jan 7th announcement of the @remap_cap IL-6ra results: https://www.medrxiv.org/content/10.1101/2021.01.07.21249390v2 and last nights @BMJ_Latest RCT drop: https://www.bmj.com/content/372/bmj.n84let’s talk about tocilizumab [threa

Francisco Marty, MD

FranciscoMarty_

With the .@NIAIDNews #ACCT1 trial final report published on 05 Nov 2020 and the .@WHO's #SolidarityTrial Preliminary report published on 02 December 2020, thought it would be good to take

Eric Meyerowitz, MD

EricMeyerowitz

1/ Thoughts on the exciting world of tocilizumab for treatment of COVID-19.RECOVERY tocilizumab preprint posted earlier today is another landmark paper and an enormous contribution to our expanding COVID-19 treatment

Bob Wachter

Bob_Wachter

1/ Covid (@UCSF) Chronicles, Day 247Fabulous @UCSF Covid Grand Rounds today: @DrPaulOffit @Penn on vaccines, @annieluet on treatments: https://tinyurl.com/y6swyu9e I’ll start with a few SF & national updates, then summarize

Roby Bhattacharyya

roby_bhatt

At the risk of shouting into the void, on papers from 2020 that most changed how I think abt COVID, as an ID physician-scientist. 280-char summaries + URLs for

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.